We are monitoring the impact of COVID-19 on Europe Flow Cytometry Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 2106
Share on
Share on

Europe Flow Cytometry Market Research Report – Segmented By Technology, By Product, By Application, By End-users & By Country(UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 2106
Pages: 137

Europe Flow Cytometry Market Size (2021 to 2026)

The size of the Flow Cytometry market in Europe has been estimated at USD 1263.85 Million in 2021. It is projected to reach USD 2026.21 Million by 2026, at a CAGR of 9.9% during the forecast period.

Flow cytometry is widely utilized in cancer and immunodeficiency diagnosis. The flow cytometry market in Europe is projected to be driven by the rising prevalence of various diseases throughout the forecast period. The European Flow cytometry market is further projected to be fuelled by the increasing prevalence of targeted diseases. Also, the rising awareness towards health concerns and increasing chromosomal defects are expected to influence the market growth.

In addition, the proliferation of chronic and contagious diseases and the recent global pandemic is uplifting the market growth during the forecast period. The introduction of new flow cytometry technologies is expected to enhance the market growth. Furthermore, in the forecast period, product innovation in diagnostic reagents, extensive applications of flow cytometry in clinical research, stem cell research, and increasing technical improvement in the area of flow cytometry is expected to accelerate the market's growth. 

The regional market players play an essential part in developing technologies for innovative instruments to enhance customer satisfaction, which has shown to help lead the fastest market growth and obtain a prominent share in the coming years. Growing awareness about a cancer diagnosis will likely create attractive growth opportunities for the flow cytometry market during the projected period. Furthermore, the adverse effects of chemotherapy and radiation therapy in cancer treatment have increased physicians' preference for autologous and allogeneic stem cell treatments, which is expected to boost the market's growth.

However, the lack of awareness among the potential users and the dearth of skilled professionals are expected to hinder the market growth. Also, the high cost associated with the instruments and reagents is expected to impede market growth. 

This research report on the European Flow Cytometry market has been segmented and sub-segmented into the following categories:

By Technology: 

  • Cell-based
  • Bead-based

By Product: 

  • Reagents & Consumables
  • Flow Cytometry Instruments

By Application: 

  • Research
  • Clinical
  • Industrial

By End-users: 

  • Commercial Organizations
  • Research Institutes
  • Clinical Testing Labs

By Country: 

  • UK
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe

Regionally, the European flow cytometry market held the second-largest share in the global market during the forecast period. Advances have mostly influenced the use of flow cytometry in immunology and other areas of cancer research. Although end-users, academics, and research institutes account for the majority of the market and are growing at the fastest rate due to flow cytometry, researchers are aided in various ways, including the rapid examination of various individual cell types within a population of cells suspended in fluid. The most well-known use of flow cytometry is immunophenotyping or the classification of cell subpopulations based on differentiation antigens. The major growth contributors in the region are UK, Germany, and France. 

The German flow cytometry market accounted for the largest share of the flow cytometry market and likely continue its growth throughout the forecast period. The market growth is attributed to the availability of advanced technology and increasing healthcare spending. However, increasing the focus of the key market players for adopting effective strategies and policies to gain a competitive advantage over the marketplace is expected to expand the market growth.

On the other hand, the UK flow cytometry market is likely to anticipate the highest share in the flow cytometry market and expand the European regional market growth. The increasing prevalence of diseases such as cancer and HIV are majorly driving the market growth. Furthermore, high-performance flow cytometers and high-speed cell sorters are widely used in research fields such as HIV, cancer, stem cell, and drug development, propelling the market's growth. As a result, it is predicted that the flow cytometry market is predicted to grow more effectively throughout the forecasted period.

KEY MARKET PLAYERS:

A few of the companies playing a significant role in the Europe Flow Cytometry Market profiled in this report are Becton, Dickinson and Company, Beckman Coulter, Inc., Thermo Fisher Scientific, Inc., Merck KGaA, Sysmex Partec GmbH, Luminex Corporation, Miltenyi Biotec GmbH, Bio-Rad Laboratories, Inc., Sony Biotechnology, Life Technologies Corporation Inc., EMD Millipore Corporation, Miltenyi Biotec, Thermo Fischer Scientific, Agilent Technologies, Inc. and Affymetix Inc.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Technology                 

                                5.1.1 Introduction           

                                5.1.2 Cell-based               

                                5.1.3 Bead-based            

                                5.1.4  Y-o-Y Growth Analysis, By Technology       

                                5.1.5  Market Attractiveness Analysis, By Technology     

                                5.1.6  Market Share Analysis, By Technology       

                5.2 Product                        

                                5.2.1 Introduction           

                                5.2.2 Reagents & Consumables 

                                5.2.3 Flow Cytometry Instruments          

                                                5.2.3.1 Cell Analyzers

                                                5.2.3.2 Cell Sorters

                                5.2.5  Y-o-Y Growth Analysis, By Product              

                                5.2.6  Market Attractiveness Analysis, By Product            

                                5.2.7  Market Share Analysis, By Product              

                5.3 Application                 

                                5.3.1 Introduction           

                                5.3.2 Research Applications        

                                                5.3.2.1 Pharmaceutical & Biotechnology

                                                5.3.2.2 Immunology

                                                5.3.2.3 Apoptosis

                                                5.3.2.4 Cell Cycle Analysis

                                                5.3.2.5 Cell Sorting

                                                5.3.2.6 Cell Viability

                                                5.3.2.7 Other Research Applications

                                5.3.3 Clinical Applications             

                                                5.3.3.1 Cancer

                                                5.3.3.2 Immunodeficiency Diseases

                                                5.3.3.3 Hematology

                                                5.3.3.4 Organ Transplantation

                                                5.3.3.5 Other Clinical Applications

                                5.3.4 Industrial Applications        

                                5.3.7  Y-o-Y Growth Analysis, By Application        

                                5.3.8  Market Attractiveness Analysis, By Application      

                                5.3.9  Market Share Analysis, By Application       

                5.3 End-users                    

                                5.3.1 Introduction           

                                5.3.2 Commercial Organizations

                                5.3.3 Hospitals  

                                5.3.4  Academic Institutions & Medical Schools  

                                5.3.5  Clinical Testing Labs            

                                5.3.6  Research Institutes            

                                5.3.7  Y-o-Y Growth Analysis, By End-users          

                                5.3.8  Market Attractiveness Analysis, By End-users        

                                5.3.9  Market Share Analysis, By End-users          

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Technology

                                                6.1.3.3 By Product

                                                6.1.3.4 By Application

                                                6.1.3.5 By End-users

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Technology

                                                6.1.4.3 By Product

                                                6.1.4.4 By Application

                                                6.1.4.5 By End-users

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Technology

                                                6.1.5.3 By Product

                                                6.1.5.4 By Application

                                                6.1.5.5 By End-users

                6.2 U.K                 

                6.3 Spain                             

                6.4 Germany                     

                6.5 Italy                               

                6.6 France                          

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 Becton, Dickinson and Company                       

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Beckman Coulter, Inc.                            

                8.3 Thermo Fisher Scientific, Inc.                              

                8.4 Merck KGaA                               

                8.5 Sysmex Partec GmbH                            

                8.6 Luminex Corporation                             

                8.7 Miltenyi Biotec GmbH                            

                8.8 Bio-Rad Laboratories, Inc.                    

                8.9 Sony Biotechnology                

                8.10 Life Technologies Corporation Inc.                 

                8.11 EMD Millipore Corporation                

                8.12 Miltenyi Biotec                       

                8.13 Thermo Fischer Scientific                   

                8.14 Agilent Technologies, Inc.                  

                8.15 Affymetix Inc.                         

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Flow Cytometry Market By Technology, From 2021to 2026 (USD Million)
  2. Europe Cell-based Market By Region, From 2021to 2026 (USD Million)
  3. Europe Bead-based Market By Region, From 2021to 2026 (USD Million)
  4. Europe Flow Cytometry Market By Product, From 2021to 2026 (USD Million)
  5. Europe Reagents & Consumables Market By Region, From 2021to 2026 (USD Million)
  6. Europe Flow Cytometry Instruments Market By Region, From 2021to 2026 (USD Million)
  7. Europe Flow Cytometry Market By Application, From 2021to 2026 (USD Million)
  8. Europe Research Applications Market By Region, From 2021to 2026 (USD Million)
  9. Europe Clinical Applications Market By Region, From 2021to 2026 (USD Million)
  10. Europe Industrial Applications Market By Region, From 2021to 2026 (USD Million)
  11. Europe Flow Cytometry Market By End-users, From 2021to 2026 (USD Million)
  12. Europe Commercial Organizations Market By Region, From 2021to 2026 (USD Million)
  13. Europe Hospitals Market By Region, From 2021to 2026 (USD Million)
  14. Europe Academic Institutions & Medical Schools Market By Region, From 2021to 2026 (USD Million)
  15. Europe Clinical Testing Labs Market By Region, From 2021to 2026 (USD Million)
  16. Europe Research Institutes Market By Region, From 2021to 2026 (USD Million)
  17. U.K. Flow Cytometry Market By Technology, From 2021to 2026 (USD Million)
  18. U.K. Flow Cytometry Market By Product, From 2021to 2026 (USD Million)
  19. U.K. Flow Cytometry Market By Application, From 2021to 2026 (USD Million)
  20. U.K. Flow Cytometry Market By End-users, From 2021to 2026 (USD Million)
  21. Germany Flow Cytometry Market By Technology, From 2021to 2026 (USD Million)
  22. Germany Flow Cytometry Market By Product, From 2021to 2026 (USD Million)
  23. Germany Flow Cytometry Market By Application, From 2021to 2026 (USD Million)
  24. Germany Flow Cytometry Market By End-users, From 2021to 2026 (USD Million)
  25. France Flow Cytometry Market By Technology, From 2021to 2026 (USD Million)
  26. France Flow Cytometry Market By Product, From 2021to 2026 (USD Million)
  27. France Flow Cytometry Market By Application, From 2021to 2026 (USD Million)
  28. France Flow Cytometry Market By End-users, From 2021to 2026 (USD Million)
  29. Italy Flow Cytometry Market By Technology, From 2021to 2026 (USD Million)
  30. Italy Flow Cytometry Market By Product, From 2021to 2026 (USD Million)
  31. Italy Flow Cytometry Market By Application, From 2021to 2026 (USD Million)
  32. Italy Flow Cytometry Market By End-users, From 2021to 2026 (USD Million)
  33. Spain Flow Cytometry Market By Technology, From 2021to 2026 (USD Million)
  34. Spain Flow Cytometry Market By Product, From 2021to 2026 (USD Million)
  35. Spain Flow Cytometry Market By Application, From 2021to 2026 (USD Million)
  36. Spain Flow Cytometry Market By End-users, From 2021to 2026 (USD Million)
  37. Europe Flow Cytometry Instruments Market By Flow Cytometry Instruments, From 2021to 2026 (USD Million)
  38. Europe Cell Analyzers Market By Region, From 2021to 2026 (USD Million)
  39. Europe Cell Sorters Market By Region, From 2021to 2026 (USD Million)
  40. U.K. Flow Cytometry Instruments Market By Flow Cytometry Instruments, From 2021to 2026 (USD Million)
  41. Germany Flow Cytometry Instruments Market By Flow Cytometry Instruments, From 2021to 2026 (USD Million)
  42. France Flow Cytometry Instruments Market By Flow Cytometry Instruments, From 2021to 2026 (USD Million)
  43. Italy Flow Cytometry Instruments Market By Flow Cytometry Instruments, From 2021to 2026 (USD Million)
  44. Spain Flow Cytometry Instruments Market By Flow Cytometry Instruments, From 2021to 2026 (USD Million)
  45. Europe Research Applications Market By Research Applications, From 2021to 2026 (USD Million)
  46. Europe Pharmaceutical & Biotechnology Market By Region, From 2021to 2026 (USD Million)
  47. Europe Immunology Market By Region, From 2021to 2026 (USD Million)
  48. Europe Apoptosis Market By Region, From 2021to 2026 (USD Million)
  49. Europe Cell Cycle Analysis Market By Region, From 2021to 2026 (USD Million)
  50. Europe Cell Sorting Market By Region, From 2021to 2026 (USD Million)
  51. Europe Cell Viability Market By Region, From 2021to 2026 (USD Million)
  52. U.K. Research Applications Market By Research Applications, From 2021to 2026 (USD Million)
  53. Germany Research Applications Market By Research Applications, From 2021to 2026 (USD Million)
  54. France Research Applications Market By Research Applications, From 2021to 2026 (USD Million)
  55. Italy Research Applications Market By Research Applications, From 2021to 2026 (USD Million)
  56. Spain Research Applications Market By Research Applications, From 2021to 2026 (USD Million)
  57. Europe Clinical Applications Market By Clinical Applications, From 2021to 2026 (USD Million)
  58. Europe Cancer Market By Region, From 2021to 2026 (USD Million)
  59. Europe Immunodeficiency Diseases Market By Region, From 2021to 2026 (USD Million)
  60. Europe Hematology Market By Region, From 2021to 2026 (USD Million)
  61. Europe Organ Transplantation Market By Region, From 2021to 2026 (USD Million)
  62. Europe Other Clinical Applications Market By Region, From 2021to 2026 (USD Million)
  63. U.K. Clinical Applications Market By Clinical Applications, From 2021to 2026 (USD Million)
  64. Germany Clinical Applications Market By Clinical Applications, From 2021to 2026 (USD Million)
  65. France Clinical Applications Market By Clinical Applications, From 2021to 2026 (USD Million)
  66. Italy Clinical Applications Market By Clinical Applications, From 2021to 2026 (USD Million)
  67. Spain Clinical Applications Market By Clinical Applications, From 2021to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample